Market Value2,318,883,000
Total Holdings59
File Date2014-02-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
REGN / Regeneron Pharmaceuticals, Inc.
AKRX / Akorn, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc.
ISRG / Intuitive Surgical, Inc.
NPSP / NPS Pharmaceuticals Inc
RLYP / Relypsa, Inc.
XLRN / Acceleron Pharma Inc
CLVS / Clovis Oncology Inc
MDVN / Medivation, Inc.
KPTI / Karyopharm Therapeutics Inc.
KERX / Keryx Biopharmaceuticals, Inc.
WX / Wuxi Pharmatech (Cayman) Inc.
G0083B108 / Actavis
PCYC / Pharmacyclics
US60877T1007 / Momenta Pharmaceuticals, Inc.
INVA / Innoviva, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
GEVA / Synageva Biopharma Corp
PRGO / Perrigo Company plc
WMGIZ / Wright Medical Group N.V.
COV /
CLDX / Celldex Therapeutics, Inc.
VIROPHARMA INC / (928241108)
SHPG / Shire Plc.
OMED / OptMed Inc
HTWR / Heartware International Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
EVAC / EQV Ventures Acquisition Corp. II
CELG / Celgene Corp.
HOLX / Hologic, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
TNDM / Tandem Diabetes Care, Inc.
ALGN / Align Technology, Inc.
018490100 / Allergan plc
ARIA / ARIAD Pharmaceuticals, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
0PP / Portola Pharmaceuticals Inc
TMO / Thermo Fisher Scientific Inc.
PTCT / PTC Therapeutics, Inc.
US00C4U1L353 / Mylan N.V.
UTHR / United Therapeutics Corporation
PFE / Pfizer Inc.
SGEN / Seagen Inc
MNKKQ / Mallinckrodt Plc
SGNT / Sagent Pharmaceuticals, Inc.
ARAY / Accuray Incorporated
DXCM / DexCom, Inc.
NXTM / NxStage Medical, Inc.
ILMN / Illumina, Inc.
IMGN / ImmunoGen, Inc.
AMGN / Amgen Inc.
ABBV / AbbVie Inc.
BIIB / Biogen Inc.
INSM / Insmed Incorporated
VRTX / Vertex Pharmaceuticals Incorporated
MRK / Merck & Co., Inc.
BMRN / BioMarin Pharmaceutical Inc.
IONS / Ionis Pharmaceuticals, Inc.
BSX / Boston Scientific Corporation
HALO / Halozyme Therapeutics, Inc.
INCY / Incyte Corporation
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)